Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT04419337
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Registry
-
NCT04419337
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Unknown status
Technical summary
Registry record NCT04419337. Randomized; no masking; primary purpose treatment. Start 2019-09-15 (actual); primary completion 2023-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke
- Condition
- Diabetes Mellitus
- Condition
- Stroke
- Intervention (Drug)
- Metformin plus Pioglitazone plus an SGLT2 inhibitor
- Lead sponsor
- Chang Gung Memorial Hospital
- Collaborator
- National Taiwan University Hospital
- Collaborator
- Chiayi Christian Hospital
- Collaborator
- Tainan Sin-lau Hospital
Record details
- Record id
cardio:ct-nct04419337- Content hash
6891a8d00344fc5c74de9317ea0cfda3f885be25a1c66257f2e7e88b3943ce2e